Validose
PrivateLast Round
Pre Seed
Feb 18, 2025
Total Funding Raised
$2M
Company Overview
Validose is a healthtech company that provides a medication adherence platform using a smart dosing device and real-time data to improve patient outcomes in clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Devices, Patient Engagement, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Validose Comparables
Compare Validose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pill Connect Limited | 88% | |
| Information Mediary Corp. | 78% | |
| AARDEX Group | 77% | |
Validose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 18, 2025 |
Validose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 10XBeta | Pre Seed |
| Interstate Fusion Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
$2M raised in Pre Seed round.
Validose Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Validose's valuation, stock price, and market status.